206 related articles for article (PubMed ID: 29517899)
21. Development of Activity-Based Proteomic Probes for Protein Citrullination.
Nemmara VV; Thompson PR
Curr Top Microbiol Immunol; 2019; 420():233-251. PubMed ID: 30203394
[TBL] [Abstract][Full Text] [Related]
22. The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.
Causey CP; Jones JE; Slack JL; Kamei D; Jones LE; Subramanian V; Knuckley B; Ebrahimi P; Chumanevich AA; Luo Y; Hashimoto H; Sato M; Hofseth LJ; Thompson PR
J Med Chem; 2011 Oct; 54(19):6919-35. PubMed ID: 21882827
[TBL] [Abstract][Full Text] [Related]
23. Noncovalent Protein Arginine Deiminase (PAD) Inhibitors Are Efficacious in Animal Models of Multiple Sclerosis.
Tejeda EJC; Bello AM; Wasilewski E; Koebel A; Dunn S; Kotra LP
J Med Chem; 2017 Nov; 60(21):8876-8887. PubMed ID: 29045782
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.
Subramanian V; Knight JS; Parelkar S; Anguish L; Coonrod SA; Kaplan MJ; Thompson PR
J Med Chem; 2015 Feb; 58(3):1337-44. PubMed ID: 25559347
[TBL] [Abstract][Full Text] [Related]
25. A FluoPol-ABPP PAD2 high-throughput screen identifies the first calcium site inhibitor targeting the PADs.
Lewallen DM; Bicker KL; Madoux F; Chase P; Anguish L; Coonrod S; Hodder P; Thompson PR
ACS Chem Biol; 2014 Apr; 9(4):913-21. PubMed ID: 24467619
[TBL] [Abstract][Full Text] [Related]
26. Targeting citrullination in autoimmunity: insights learned from preclinical mouse models.
Bruggeman Y; Sodré FMC; Buitinga M; Mathieu C; Overbergh L; Kracht MJL
Expert Opin Ther Targets; 2021 Apr; 25(4):269-281. PubMed ID: 33896351
[TBL] [Abstract][Full Text] [Related]
27. Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.
Witalison EE; Thompson PR; Hofseth LJ
Curr Drug Targets; 2015; 16(7):700-10. PubMed ID: 25642720
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?
Padhy DS; Palit P; Ikbal AMA; Das N; Roy DK; Banerjee S
Inflammopharmacology; 2023 Apr; 31(2):731-744. PubMed ID: 36806957
[TBL] [Abstract][Full Text] [Related]
29. Current knowledge into the role of the peptidylarginine deiminase (PAD) enzyme family in cardiovascular disease.
Al-U'datt DGF; Allen BG; Hiram R; Alrabadi N
Eur J Pharmacol; 2021 Jan; 891():173765. PubMed ID: 33249073
[TBL] [Abstract][Full Text] [Related]
30. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
31. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
32. The protein arginine deiminases: Structure, function, inhibition, and disease.
Bicker KL; Thompson PR
Biopolymers; 2013 Feb; 99(2):155-63. PubMed ID: 23175390
[TBL] [Abstract][Full Text] [Related]
33. Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice.
Sodré FMC; Bissenova S; Bruggeman Y; Tilvawala R; Cook DP; Berthault C; Mondal S; Callebaut A; You S; Scharfmann R; Mallone R; Thompson PR; Mathieu C; Buitinga M; Overbergh L
Diabetes; 2021 Feb; 70(2):516-528. PubMed ID: 33203696
[TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharide-induced neutrophil extracellular trap formation in canine neutrophils is dependent on histone H3 citrullination by peptidylarginine deiminase.
Li RHL; Ng G; Tablin F
Vet Immunol Immunopathol; 2017 Dec; 193-194():29-37. PubMed ID: 29129225
[TBL] [Abstract][Full Text] [Related]
35. Murine Retinal Citrullination Declines With Age and is Mainly Dependent on Peptidyl Arginine Deiminase 4 (PAD4).
Hollingsworth TJ; Radic MZ; Beranova-Giorgianni S; Giorgianni F; Wang Y; Iannaccone A
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3808-3815. PubMed ID: 30073354
[TBL] [Abstract][Full Text] [Related]
36. Citrullination regulates the expression of insulin-like growth factor-binding protein 1 (IGFBP1) in ovine uterine luminal epithelial cells.
Young CH; Rothfuss HM; Gard PF; Muth A; Thompson PR; Ashley RL; Cherrington BD
Reproduction; 2017 Jan; 153(1):1-10. PubMed ID: 29565015
[TBL] [Abstract][Full Text] [Related]
37. Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase.
Damgaard D; Bjørn ME; Steffensen MA; Pruijn GJ; Nielsen CH
Arthritis Res Ther; 2016 May; 18(1):102. PubMed ID: 27149996
[TBL] [Abstract][Full Text] [Related]
38. Red-Shifting Azobenzene Photoswitches for in Vivo Use.
Dong M; Babalhavaeji A; Samanta S; Beharry AA; Woolley GA
Acc Chem Res; 2015 Oct; 48(10):2662-70. PubMed ID: 26415024
[TBL] [Abstract][Full Text] [Related]
39. Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
Lange S; Gallagher M; Kholia S; Kosgodage US; Hristova M; Hardy J; Inal JM
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587234
[TBL] [Abstract][Full Text] [Related]
40. Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
Dreyton CJ; Anderson ED; Subramanian V; Boger DL; Thompson PR
Bioorg Med Chem; 2014 Feb; 22(4):1362-9. PubMed ID: 24440480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
